Amoebicidal activity of curcumin on Entamoeba histolytica trophozoites

This study was undertaken to investigate the amoebicidal potential of curcumin on Entamoeba histolytica, as well as its synergistic effect with metronidazole. Entamoeba histolytica trophozoites were exposed to 100, 200 and 300 μm of curcumin, for 6, 12 and 24 h. Consequently, the viability of cells...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy and pharmacology Vol. 70; no. 3; p. 426
Main Authors Rangel-Castañeda, Itzia Azucena, Hernández-Hernández, José Manuel, Pérez-Rangel, Armando, González-Pozos, Sirenia, Carranza-Rosales, Pilar, Charles-Niño, Claudia Lisette, Tapia-Pastrana, Gabriela, Ramírez-Herrera, Mario Alberto, Castillo-Romero, Araceli
Format Journal Article
LanguageEnglish
Published England 01.03.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:This study was undertaken to investigate the amoebicidal potential of curcumin on Entamoeba histolytica, as well as its synergistic effect with metronidazole. Entamoeba histolytica trophozoites were exposed to 100, 200 and 300 μm of curcumin, for 6, 12 and 24 h. Consequently, the viability of cells was determined by trypan blue exclusion test. All specimens were further analysed by scanning electron microscopy. For drug combination experiment, the Chou-Talalay method was used. Curcumin affected the growth and cell viability in a time- and dose-dependent manner. The higher inhibitory effects were observed with 300 μm at 24 h; 65.5% of growth inhibition and only 28.8% of trophozoites were viable. Additionally, curcumin also altered adhesion and the morphology of the trophozoites. Scanning electron microscopy revealed treated trophozoites with damages on the membrane, size alterations and parasites with loss of cellular integrity. In addition, the combination of curcumin + metronidazole exhibited a synergistic effect; the activity of both drugs was improved. This is the first report evaluating the effectiveness of curcumin against E. histolytica. Our results suggest that CUR could be considered for evaluation in future pharmacological studies as a promising amoebicidal agent or as complementary therapy.
ISSN:2042-7158
DOI:10.1111/jphp.12867